Repeated measures screening for Down's Syndrome

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 112, Issue 1, 2005, Pages 80-83

  Wright, David E ^a   Bradbury, Ian ^b  

^a UNIVERSITY OF PLYMOUTH   (United Kingdom)

^b UNIVERSITY OF ULSTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MARKER; PREGNANCY ASSOCIATED PLASMA PROTEIN A; UBIQUITIN PROTEIN LIGASE E3;

ARTICLE; DOWN SYNDROME; FETUS ECHOGRAPHY; FIRST TRIMESTER PREGNANCY; HUMAN; LABORATORY DIAGNOSIS; MATERNAL AGE; MONTE CARLO METHOD; PRENATAL SCREENING; PRIORITY JOURNAL; SCREENING TEST; SECOND TRIMESTER PREGNANCY; UNITED KINGDOM;

BIOLOGICAL MARKERS; CHORIONIC GONADOTROPIN; DOWN SYNDROME; ENDOPEPTIDASES; ESTRADIOL; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; INHIBINS; MONTE CARLO METHOD; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, SECOND; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PRENATAL DIAGNOSIS;

EID: 11844285681     PISSN: 14700328     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2004.00343.x     Document Type: Article

References (9)

1. Wald NJ, Watt HC, Hackshaw AK. Integrated screening for Down's syndrome on the basis of tests performed during the first and second trimesters. N Engl J Med 1999;341(7):461-467.
2. Wald NJ, Rodeck C, Hackshaw AK, et al. First and second trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS). Health Technol Assess (Winch) 2003;7(11):1-77.
3. Wright DE, Bray I. Estimating birth prevalence of Down's syndrome. J Epidemiol Biostat 2000;5(2):89-97.
4. Office for National Statistics. Birth Statistics, Series FMI, Numbers 25-27, 1998 [1996, 1997, 1998].
5. Aitchison J, Dunsmore IR. Statistical Prediction Analysis. Cambridge: Cambridge University Press, 1975.
6. Cuckle HS. Growing complexity in the choice of Down's syndrome screening policy. Ultrasound Obstet Gynecol 2002;19(4):323-326.
7. Copel JA, Bahado-Singh RO. Prenatal screening for Down's syndrome - a search for the family's values. N Engl J Med 1999; 341(7):521-522.
8. Herman A, Dreazen E, Tovbin J, Weinraub Z, Bukovsky Y, Maymon R. Comparison between disclosure and non-disclosure approaches for trisomy 21 screening tests. Hum Reprod (Oxf) 2002;17(5):1358-1362.
9. Wright DE, Bradbury I, Benn P, Cuckle H, Ritchie K. Contingent screening for Down's syndrome is an efficient alternative to non-disclosure sequential screening. Prenatal Diagnosis. In press.